Atriyal Fibrilasyon Kateter Ablasyonu Başarısı ve Rekürrensin Strain Ekokardiyografi ve Kardiyak Mrg T1 Haritalama ile İlişkisi
View/ Open
Date
2018Author
Çöteli, Cem
xmlui.dri2xhtml.METS-1.0.item-emb
Acik erisimxmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Atrial fibrillation is a common arrithymia which is caracterized with atrial fibrosis in all
aged population. Success rate of atrial fibrillation treatment is lower in patients have
high atrial fibrosis. In this trial, we aimed to evaluate atrial fibrosis burden with some
clinical parameters. In this prospective clinical study, 30 patients which are planned
for atrial fibrillation catheter ablation with cryo-energy in Hacettepe University Adult
Hospital Cardiology Clinic were enrolled. In addition to rutine clinical examination,
patients were examined with cardiac MRI and transthoracic echocardiography. Blood
sampling was done from left atrial cavity and peripheral vessels during the procedure.
It was aimed that atrial disease level of patients were evaluated with cardiac MRI T1
relaxation time and transthoracic echocardiography parameters and blood levels of
FGF-21 and FGF-23 which are fibrosis biomarkers. After the procedure, patients were
followed for 12 months. Four of 30 patients had recurrences of atrial fibrillation during
follow-up. We aimed to examine relationship between atrial fibrosis markers and the
success of atrial fibrillation catheter ablation. Post contrast T1 relaxation time which
was calculated in posterior left atrium was shorter in patients which had recurrences
(325,75±27,11 ms; 431,41±52,59 ms; p=0,004). Blood levels of FGF-21 were not
different neither santral nor peripheral between groups (patients without recurrences
santral: 230,15±147,35 pg/ml, peripheral: 196,50±114,60 pg/ml; patients with
recurrences santral:182,00±96,73 pg/ml, peripheral:128,25±76,36 pg/ml; p=0,625;
p=0,300). Blood levels of FGF-23 were lower in patients without recurrences than
patients with recurrences (patients without recurrences peripheral: 1946,54±302,95
pg/ml, santral:1848,20±286,05 pg/ml; patients with recurrences peripheral:
2392,53±199,00 pg/ml, santral:2367,93±162,86 pg/ml; p=0,009; p=0,002). Left atrial
volüme index (56,00±13,04ml/2
- 27,31±11,41ml/m2
; p=0,003) and left atrial passive
empty fraction (%23,75±5,85 - %13,69±9,51; p=0,025) were higher in patients with
recurrences. Left atrial active empty fraction (%14,50±4,20 - %29,65±11,46 p=0,008)
and peak atrial reservoir strain (%14,00±4,51 - %21,64±7,02; p=0,019) were lower in
patients with recurrences. Left atrial contraction strain index (%70,75±5,38 -
%56,15±11,51 p=0,024) was higher in patients with recurrences. In conclusion, this
study showed that cardiac MRI left atrial T1 relaxation time, blood levels of FGF-23,
volumes of left atrium and left atrial strain could predict the success possibility of atrial
fibrillation catheter ablation procedure. Large scaled, prospective, randomized trials
and long-term outcome data are essential to understand the role of these parameters
about atrial fibrillation catheter ablation success prediction and to use routinely in clinic
approach.